Vanguard Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Vanguard Capital Management's MIRM Position: Q3 2026 in Review
Vanguard Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 11% in Q3 2026, buying an estimated $25.5M and bringing the position to 2,498,555 shares worth $214M. The position accounts for ﹤0.01% of the portfolio, ranked #1062.
Vanguard Capital Management first reported a position in MIRM in Q1 2026 and has held it in 3 quarters since. The position peaked at $264M in Q2 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Vanguard Capital Management held 2,498,555 shares of Mirum Pharmaceuticals worth $214M as of Q3 2026.
- Vanguard Capital Management bought 244,446 Mirum Pharmaceuticals shares in Q3 2026, an estimated $25.5M.
- Mirum Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1062 holding.
- Vanguard Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Mirum Pharmaceuticals position peaked at $264M in Q2 2026.
- 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.